NU Skin Enterprises Inc.

NUS NYS
Pharmaceuticals
Provo, UT
2016 Revenue (US$ Millions)$2,208
Revenue Growth (%)-1.75%
2015 Revenue (US$ Millions)$2,247
Net Income (US$ Millions)$143
Common Shares Outstanding (Millions)52.6
Earnings Per Share (US$)$2.55
Price to Earnings Ratio25.54
Total Equity (US$ Millions)$664
Return on Equity (%)17.33%
Long Term Debt (US$ Millions)$334
Debt to Equity Ratio (%)0.50%
Market Capitalization (US$ Millions)$2,513
Total Assets (US$ Millions)$1,474
Current Assets (US$ Millions)$714
Inventories (US$ Millions)$250
Current Liabilities (US$ Millions)$399
Cost Of Goods Sold (US$ Millions)$500
Asset Turnover1.48
Inventory Turnover1.94